aluminum hydroxide, magnesium hydroxide, drug combination has been researched along with calcitriol in 1 studies
Studies (aluminum hydroxide, magnesium hydroxide, drug combination) | Trials (aluminum hydroxide, magnesium hydroxide, drug combination) | Recent Studies (post-2010) (aluminum hydroxide, magnesium hydroxide, drug combination) | Studies (calcitriol) | Trials (calcitriol) | Recent Studies (post-2010) (calcitriol) |
---|---|---|---|---|---|
253 | 100 | 17 | 16,107 | 1,224 | 3,710 |
Protein | Taxonomy | aluminum hydroxide, magnesium hydroxide, drug combination (IC50) | calcitriol (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0093 | |
Vitamin D3 receptor | Homo sapiens (human) | 0.3401 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 0.0093 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balena, R; Foldes, J; Ho, A; Kleerekoper, M; Parfitt, AM | 1 |
1 other study(ies) available for aluminum hydroxide, magnesium hydroxide, drug combination and calcitriol
Article | Year |
---|---|
Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid.
Topics: Adolescent; Aluminum Hydroxide; Antacids; Calcitriol; Calcium; Drug Administration Schedule; Drug Combinations; Humans; Hydroxyproline; Intellectual Disability; Magnesium Hydroxide; Male; Phosphates; Radiography; Rickets; Simethicone | 1991 |